Breast imaging technologies are used for the early detection of breast-related disorders. These technologies are mainly used to detect breast cancer at its initial stages. Various imaging modalities such as mammography, MRI, and ultrasound facilitate in the screening and staging of breast cancer by identifying characteristic masses or calcifications in the breast tissue.
The global breast imaging technologies market is expected to reach $4,502 million by 2022 from $2,544 million in 2015, growing at a CAGR of 8.4% during the forecast period. This market is expected to witness significant growth ahead owing to the increase in incidence of breast cancer globally and rise in initiatives by healthcare organizations to raise awareness about the early detection of breast cancer. The main drivers of the market include the need for technologically advanced products (such automated whole breast ultrasound system (AWBU)) for breast imaging and favorable reimbursement scenario. However, high cost of these imaging modalities and stringent regulatory approval processes hamper the market growth.
The breast imaging technologies market is segmented on the basis of product type and geography. Based on product type, it is bifurcated into ionizing breast imaging and non-ionizing breast imaging technologies. Ionizing breast imaging technologies include analog mammography, full-field digital mammography, 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast imaging/breast-specific gamma imaging (MBI/BSGI), cone beam computed tomography (CBCT), and positron emission mammography (PEM). On the other hand, non-ionizing breast imaging technologies are further divided into breast MRI, breast ultrasound, optical imaging, whole breast ultrasound, and breast thermography. The market is analyzed based on four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
Prominent players adopted product development (including product launches and approvals) as their key developmental strategy for expanding their product portfolio. For instance, in June 2014, GE Healthcare received FDA approval of Invenia ABUS, which is an automated breast ultrasound system used for breast cancer detection. This system helps in detecting breast cancer in women with dense tissue when used as an adjunct with a mammogram.
Key market segments
By Product Type
The key players profiled in this report are as follows:
Other players operating in the breast imaging technologies (not elaborated in the report) market include:
SIMILAR MARKET STUDIES
Glucose Meter is a medical device for determining the approximate concentration of glucose in the blood. It can also be a strip of glucose paper dipped into a substance and measured to the glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes ...
September 2017 | $4880 | View Details >>
This report studies the Pet Insurance market, Pet insurance is a type of specialty property and casualty insurance policy that pet owners purchase to cover the unintended costs that arise in providing care for a pet, including veterinary services such as surgical procedures, injuries from accidents, and prescribed pet medicines. ...
September 2017 | $4880 | View Details >>
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Biofeedback Instrument in these regions, from 2012 to 2022 (forecast), covering North America Europe China Asia (Ex. China) RoW The major players in global Biofeedback Instrument market include Thought Technology Ltd Laborie Qxsubspace Vishee Quantum World Vision BrainMaster Technologies, Inc. Mind Media NeuroCare Allengers Medical Systems ELMIKO NCC ...
September 2017 | $2900 | View Details >>
This report studies the Irreversible Electroporation Ablators market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Irreversible Electroporation Ablators market by product type and applications/end industries. The ...
September 2017 | $4000 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research